Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CDNA Transcript
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
CareDx, Inc. (CDNA) Q1 2026 Earnings Call Transcript
Positive5-4
The earnings call highlights strong financial growth for Naveris and a strategic focus on expanding testing and improving efficiency, which are positive indicators. The high attach rate for digital solutions at transplant centers and stable reimbursement rates further support a positive outlook. However, some uncertainties, such as the GYN indication timeline and lack of Naveris contribution to current revenue guidance, temper the sentiment slightly. Overall, the positive growth projections and market leadership in key areas suggest a likely positive stock price movement.
CareDx, Inc. (CDNA) Q4 2025 Earnings Call Transcript
Unknown2-25
The earnings call presents a mixed picture. Financial performance shows positive trends with increased revenue and net income, but gross margin decline is a concern. The raised revenue and EBITDA guidance are positive, yet the lack of clarity on strategic initiatives and potential risks from forward-looking statements create uncertainty. The absence of a shareholder return plan discussion and unclear management responses in the Q&A further contribute to a neutral sentiment. Without market cap data, the impact on stock price is uncertain, but the mixed signals suggest a neutral movement of -2% to 2%.
Energy Fuels Inc. (EFR:CA) Q3 2025 Earnings Call Transcript
Unknown11-4
The earnings call presents a mixed outlook. Positive aspects include the decline in uranium production costs and strong margins, but these are offset by uncertainties in project timelines and vague management responses. The Q&A reveals concerns about strategic decisions and lack of clarity on partnerships. While the convertible note offering boosts liquidity, the lack of acceleration in key projects and unclear guidance tempers enthusiasm. Without a market cap, the overall sentiment remains neutral, anticipating limited stock movement.
CDNA Slides
CDNA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
